Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca to shell out £12M in severance dispute with workers at former England plant
Fierce Pharma
Thu, 07/18/19 - 12:00 pm
Tags:
AstraZeneca, UK
Exclusive interview with AstraZeneca ahead of upcoming Wearable Injectors & Connected Devices
Pharmaforum
Wed, 07/17/19 - 09:48 am
Tags:
AstraZeneca, devices, wearables, injectors
AstraZeneca’s Imfinzi gets FDA orphan drug status for small cell lung cancer
Pharmaceutical Business Review
Tue, 07/16/19 - 10:59 am
Tags:
AstraZeneca, Imfinzi, FDA, small cell lung cancer, orphan drugs
AstraZeneca's Farxiga fails to get U.S. approval for Type-1 diabetes
Yahoo/Reuters
Mon, 07/15/19 - 09:58 am
Tags:
AstraZeneca, FDA, Farxiga, type 1 diabetes
NICE recommends funding for psoriasis and type 1 diabetes drugs
Pharmaforum
Fri, 07/12/19 - 12:14 pm
Tags:
NICE, UK, NHS, AbbVie, Skyrizi, AstraZeneca, Farxiga
Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs
Xconomy
Thu, 07/11/19 - 11:15 pm
Tags:
Alzheimer's disease, BACE inhibitors, Merck, Eli Lilly, AstraZeneca, Amgen, Novartis, Biogen Eisai
AstraZeneca Has Dazzled in Recent Cancer Trials, but Faces Stiff Competition
BioSpace
Thu, 06/27/19 - 06:38 pm
Tags:
AstraZeneca, clinical trials, Imfinzi, extensive-stage small cell lung cancer, Calquence, CLL
AZ’s Imfinzi on target in small cell lung cancer, sets up Roche rivalry
Pharmaforum
Thu, 06/27/19 - 09:34 am
Tags:
AstraZeneca, Imfinzi, extensive-stage small cell lung cancer, Roche, Tecentriq
Abbvie proves the best at getting the most out of its workers
EP Vantage
Fri, 06/21/19 - 09:44 am
Tags:
AbbVie, Bristol-Myers Squibb, Sanofi, AstraZeneca, revenue per employee
AstraZeneca's Lynparza gets EU nod as first-line ovarian cancer maintenance treatment
Yahoo/Reuters
Tue, 06/18/19 - 10:04 am
Tags:
AstraZeneca, Lynparza, ovarian cancer, Europe
AstraZeneca's Calquence sets Imbruvica in its sights with big CLL survival numbers
Fierce Pharma
Mon, 06/17/19 - 11:21 pm
Tags:
AstraZeneca, Calquence, CLL, Imbruvica
AstraZeneca spinout Viela Bio pockets $75M on its way to BLA for autoimmune drug
Endpoints
Mon, 06/17/19 - 12:21 pm
Tags:
Viela Bio, AstraZeneca, autoimmune disease
AstraZeneca commits $630M to Korean drug R&D push
Fierce Biotech
Mon, 06/17/19 - 09:58 am
Tags:
AstraZeneca, South Korea, R&D, Sweden
AstraZeneca’s Lokelma shows significant effect in ESRD trial
Pharmaceutical Business Review
Mon, 06/17/19 - 09:51 am
Tags:
AstraZeneca, Lokelma, hyperkalaemia, renal disease
Plagued by delays, AstraZeneca HQ costs soar to £750M as it edges toward 2020 completion
Endpoints
Wed, 06/12/19 - 09:38 am
Tags:
AstraZeneca, headquarters
ADA: AstraZeneca's Farxiga scores in kidney outcomes study
Fierce Pharma
Mon, 06/10/19 - 09:44 am
Tags:
AstraZeneca, ADA, Farxiga, clinical trials, renal disease
AstraZeneca ends another Calquence trial early
Pharmaforum
Thu, 06/6/19 - 09:55 am
Tags:
AstraZeneca, CLL, Calquence, clinical trials
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More
Xconomy
Wed, 06/5/19 - 10:43 am
Tags:
ASCO 2019, cancer, immunotherapy, diagnostics, Veracyte, Grail, Moderna Therapeutics, Amgen, Nektar Therapeutics, Blueprint Medicines, Merck, AstraZeneca, Roche, breast cancer
ASCO Soundbites, vol. 3: Real-time approvals, Pfizer's second rodeo and 'the busiest ASCO ever'
Fierce Pharma
Tue, 06/4/19 - 12:18 pm
Tags:
ASCO 2019, Merck, Keytruda, FDA, Pfizer, AstraZeneca, Regeneron, Libtayo, Venclexta, Gazyva
AstraZeneca scouts replacements for longtime chairman Johansson: report
Fierce Pharma
Tue, 06/4/19 - 11:05 am
Tags:
AstraZeneca, Leif Johansson

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.